六味地黄丸联合钙尔奇D治疗绝经后骨质疏松症对照观察

目的]观察六味地黄丸与钙尔奇D联合治疗绝经后骨质疏松症的临床应用价值。方法]选取我院收治的绝经后骨质疏松症患者150例,将其分为Ⅰ组、Ⅱ组、Ⅲ组,每组50例。Ⅰ组口服六味地黄丸治疗,Ⅱ组口服钙尔奇D治疗,Ⅲ组采取六味地黄丸与钙尔奇D联合治疗。均以6个月为1个疗程,连续治疗1个疗程后观测骨密度变化情况。结果]三组患者骨密度均发生不同程度的升高,且Ⅲ组患者骨密度升高程度明显高于Ⅰ组和Ⅱ组患者。用药期间,Ⅰ组有3例患者出现腹胀、反酸等反应,Ⅱ组有2例患者出现胃肠道反应,Ⅲ组有3例患者出现消化道反应,三组患者均未出现严重不良反应。结论]六味地黄丸与钙尔奇D联合治疗绝经后骨质疏松症具有良好的临床应用价值。

Six Taste Glutinous Rehmannia Pill Combined with Caltrate D in Treatment of Postmenopausal Osteoporosis Comparative Observation

Objective]To investigate Liu Wei Di Huang Wan Caltrate D joint treatment of postmenopausal osteoporosis clinical value.Methods]Our hospital the postmenopausal osteoporosis 150 patients,divided into group I,II group,III group I patients using Liu Wei Di Huang Wan treatment,all II patients treated with Caltrate D,group III patients take Liu Wei Di Huang Wan Caltrate D combination therapy,and bone mineral density changes and adverse reflect the situation of the three groups of patients after treatment.Results]After treatment,the three groups of bone mineral density in patients with varying degree rise,and III patients were obviously higher than the group I and group II in patients with bone density during the treatment,I group,3 patients bloating,acid reflux in patients reflect 2 patients had gastrointestinal reflect group II,group III patients with gastrointestinal reflect,three groups were no serious adverse reactions.Conclusion]Liu Wei Di Huang Wan Caltrate D joint treatment of postmenopausal osteoporosis with good clinical value.